Objective To investigate the prospective associations between early childhood lead exposure and subsequent risk of attention deficit hyperactivity disorder (ADHD) in childhood and its potential effect modifiers.
L
ead is a recognized environmental toxin. [1] [2] [3] [4] [5] Lead exposure has decreased significantly over the past decades since the removal of lead from paints and gasoline and the adoption of other environmental safety measures, 6 However, exposure to low lead levels continues to be widespread in the general US population, particularly in urban low-income populations. 7 To date, critical questions remain regarding the role of early life lead exposure in the development of attention deficit hyperactivity disorder (ADHD). [8] [9] [10] Existing studies used cross-sectional designs, 2, 3, 5 and lead measurement occurred either simultaneous to or after the ADHD diagnosis; thus, the temporal relationship between lead exposure and ADHD could not be established. Despite the well-observed greater likelihood of ADHD in boys compared with girls, few studies have investigated if lead affects boys and girls differently. 2 Additionally, most studies on ADHD examined lead exposure late in childhood (mean age of measurement ranging from 7 to 14 years). 10 Last, prior studies did not consider potential modifiers of the lead-ADHD association, which is necessary both in terms of understanding the etiology of ADHD and informing intervention strategies. 11 In this study, we sought to examine the association between early childhood lead exposure and the development of ADHD using a prospective birth cohort design. We were particularly interested in identifying early life factors that could modify lead-ADHD associations in a predominantly urban low-income minority population in the US. We hypothesized that there is a significant association between early childhood blood lead levels and the risk of developing ADHD. Motivated by findings from our previous work, 12 we further hypothesized that this association might be modified by prenatal factors, including child sex, maternal highdensity lipoprotein (HDL) levels, and degree of stress during pregnancy. The conceptual framework of these hypotheses is illustrated in Figure 1 (available at www.jpeds.com).
Methods
This study analyzed data from the Boston Birth Cohort (BBC), which has recruited mother-infant pairs at birth from Boston Medical Center (BMC) since 1998, using a rolling enrollment. Details of the BBC recruitment have been published previously. 13, 14 Eligible mothers were those who delivered a single live birth at BMC. Pregnancies resulting from in vitro fertilization, multiple gestation pregnancies, deliveries induced by maternal trauma, or newborns with substantial congenital disabilities were not eligible for enrollment. BBC mother-infant pairs who continued to receive pediatric primary care at BMC were enrolled in a postnatal follow-up study. 13, 15, 16 The Institutional Review Board of Boston University Medical Center and The Institutional Review Board of Johns Hopkins Bloomberg School of Public Health approved the BBC study. Informed consent was obtained from each participant under the Institutional Review Board approved protocol.
There were 3098 mother-infant pairs enrolled in the postnatal follow-up study at BMC at the time of the study. Our study sample excluded participants who had missing data for lead measurements and key covariates. We further excluded those with lead measurement after ADHD diagnosis, incorrect lead measurement dates, lead measurement age older than 4 years, and a lead level higher than 10 µg/dL (to focus on the effects in the low lead exposure range). Because many neurodevelopmental disorders may have common risk factors, we excluded those with neurodevelopmental disorder diagnoses other than ADHD (Figure 2 ; available at www.jpeds.com). Our final analyses consisted of 1479 mother-infant pairs (299 children with ADHD and 1176 neurotypical [NT] children) who were enrolled at birth from 1998 to 2013 and followedup prospectively until the end of 2016 (Figure 2) .
After recruiting mothers within 24-72 hours after delivery, a standard questionnaire interview was used to collect data on maternal demographic characteristics, smoking status, and stress during pregnancy. Stress during pregnancy was defined according to the response to the following question: "How would you characterize the amount of stress in your life during pregnancy?" The possible responses to the question included not stressful, average stressful, and very stressful. A medical abstraction form was used to review participants' medical records and collect clinical-related data including parity, pregnancyrelated complications, intrauterine infection, and birth outcomes such as gestational age and birthweight. Since 2003, electronic medical records (EMRs) were implemented for routine clinical data collection at BMC, including both wellchild and specialty medical visits. For each primary care visit, the EMRs contain the primary and secondary diagnoses from the International Classification of Diseases, Ninth Revision (ICD-9) (before October 1, 2015) and ICD-10 (after October 1, 2015) . In this study, we extracted EMR data until the end of 2016.
Maternal plasma HDL levels and lead levels in red blood cells were measured using nonfasting blood samples obtained between 24 and 72 hours after delivery. The child postnatal blood lead levels (as part of routine pediatric screening) were obtained from the EMRs. The low detection limit of lead was 2 µg/dL; 659 children had blood lead levels below this threshold. The below threshold lead level was coded as 1 µg/dL when lead was analyzed as a continuous variable. For each child with repeated measurements of lead levels, the level measured at the earliest age was selected for analysis in this study.
In our study, the ADHD group was defined as having any of the following ICD-9 codes: 314.0, 314.00, 314.01, 314.1, 314.2, 314.8, and 314.9, or any of the following ICD-10 codes: F90.0, F90.1, F90.2, F90.8, and F90.9 as documented in the child's EMRs. The NT group was defined as not having any diagnosis of autism spectrum disorder, ADHD, conduct disorders, developmental delays, intellectual disabilities, failure to thrive, and/or congenital anomalies. Table I (available at www.jpeds.com) lists the ICD-9 and ICD-10 codes for these neurodevelopmental disorders diagnoses.
The characteristics of the study sample for the ADHD and the NT groups were compared using t tests for continuous variables and c 2 tests for categorical variables. Variables with a P < .05 were included in the subsequent multivariate logistic regression (MLR) analyses as covariates. The key predictor analyzed in this study was the child's lead level, which was natural log-transformed to approximate the normal distribution. Lead level was also analyzed as a binary (5 µg/dL as the cutoff) and categorical variable (<2, 2-4, and 5-10 µg/dL) based on cutpoints used in previous studies and Centers for Disease Control and Prevention (CDC) guidelines. 2, 8 Maternal HDL levels were analyzed as a binary variable cut at the median (60.7 mg/dL). 12 Maternal stress during pregnancy was converted from a 3-category variable (not stressful, average, very stressful) into a binary variable (not stressful vs stressful) for analysis. 17 We conducted MLR to examine the dose-response association between early childhood lead level and the risk of having ADHD, both categorically and continuously, adjusting for maternal age at delivery, maternal race/ethnicity, maternal education, smoking during pregnancy, intrauterine infection, parity, child's sex, mode of delivery, preterm birth, and birthweight. Sex-stratified analyses and the joint effect of the child's sex with lead levels on the risk of ADHD diagnosis were tested using MLR, and adjusted for the same covariates except for child's sex. The interaction between child's sex and lead level on the risk of ADHD was then tested using MLR and adding the interaction term into the model while adjusting for the same covariates. We further tested the joint associations among maternal HDL level, maternal stress during pregnancy, and early childhood lead level with the risk of ADHD diagnosis both across and within the child's sex groups, adjusting for the same covariates except for child's sex. For the sensitivity analyses, Volume 199 • August 2018 we repeated these analyses within 3 subsets: one analysis did not exclude the samples with other neurodevelopmental disorders; one analysis included the samples with early childhood lead levels measured at age ≤2 years; and the third analysis further adjusted for maternal lead levels (treated as a binary variable cut at 5 µg/dL) measured right after delivery, using the samples that had measurements for both maternal and early childhood lead levels. We also performed Cox proportional hazard models using child's age until the first ADHD diagnosis or administrative censor time at the end of 2016, adjusted for the same covariates as the MLR models. All analyses were performed using STATA version 14.0 software (Stata Corporation, College Station, Texas).
Results
Data from 1479 mother-child pairs were analyzed. The median age of the children by our latest EMR extraction date (December 31, 2016) was 9.6 years (IQR, 7.4-12.5 years). Among them, 299 children (13.9% before removing children with neurodevelopmental disorders diagnoses other than ADHD) had a physician diagnosis of ADHD, and 131 children (8.9%) had lead levels of 5-10 µg/dL; 9.4% in boys and 8.3% in girls. The median age of the first diagnosis of ADHD was 6 years of age. The median age of the first lead measurement was 0.84 years (IQR, 0.77-1.03 years). The comparison results of major characteristics between excluded and included samples indicate that the included sample had less exposure to multiple risk factors, such as less educational attainment, shorter gestational age, and lower birthweight (Table II; available at www.jpeds.com). Table III presents the bivariate comparisons of maternal and child characteristics between the ADHD and NT groups. Mothers of children with any ADHD diagnosis were more likely to have less than a college degree, ever smoked before or during pregnancy, delivered by cesarean, had high stress during pregnancy, and had low HDL levels compared with the NT group. Children with an ADHD diagnosis were more likely to be male, born prematurely, and have low birthweight, compared with the NT group. Table IV shows the results for both the crude and adjusted associations of early childhood lead levels with the risk of ADHD diagnosis. When lead levels were analyzed as 3 categories, compared with those with less than 2 µg/dL lead levels, the adjusted OR for children with 2-4 µg/dL and 5-10 µg/dL lead levels was 1.08 (95% CI, 0.81-1.44) and 1.73 (95% CI, 1.09-2.73), respectively. The natural log-transformed linear trend of lead levels was significantly associated with an increased risk of ADHD diagnosis (adjusted OR, 1.25; 95% CI, 1.01-1.56). When lead was analyzed as a binary variable, children with 5-10 µg/dL lead levels had 66% increased odds of having any ADHD diagnosis as compared with children with less than 5 µg/dL lead levels (adjusted OR, 1.66; 95% CI, (1.08-2.56). A test of interaction between sex and lead level (binary) was statistically significant (the P value for interaction was .017), which was further explored as described elsewhere in this article. Figure 3 shows that the crude percentage of ADHD diagnosis was higher among boys compared with girls within each lead exposure level. Figure 4 (available at www.jpeds.com) is a Lowess plot showing a positive linear trend with the risk of ADHD diagnosis among boys, and the trend was flat among girls. Table V shows the adjusted associations between the child's lead levels and the risk of any ADHD diagnosis stratified by the child's sex and the joint effect of the child's lead levels and the child's sex on ADHD risk. When simultaneously considering child sex and lead levels, boys with 5-10 µg/dL lead levels had a 7-fold increased odds of having any ADHD diagnosis (aOR, 7.48; 95% CI, 4.29-13.02), compared with girls with the less than 5 µg/dL lead levels.
To further account for time to event, we plotted KaplanMeier survival curves stratified by child's sex and lead levels ( Figure 5 ; available at www.jpeds.com) and performed Cox proportional hazard models (Table VI; available at www.jpeds.com). Both analyses found similar associations of child sex and lead levels with ADHD diagnosis as those findings in Table V and Table VI. Table VII (available at www.jpeds.com) shows the results of the sensitivity analyses on the joint effects of early childhood lead exposure on ADHD diagnosis compared with the no ADHD group, and the findings were similar to those shown in Table V. Table VIII (available at www.jpeds.com) shows the results of the sensitivity analyses on the joint effects of early childhood lead exposure by restricting the analysis to children with lead measurements at age 2 years of age or younger, and the findings were similar. Table IX (available at www.jpeds.com) shows the results of the sensitivity analyses on the joint effects of early childhood lead exposure by further adjusting for maternal lead measurements right after delivery, and the findings were also similar. Figure 6 (available at www.jpeds.com) displays the plot of maternal lead levels vs early childhood lead levels, which suggests no clear correlation between the 2 lead measures.
Table X (available at www.jpeds.com) shows the joint association of child's sex, maternal HDL level, maternal stress during pregnancy, and early childhood lead measurement with the risk of ADHD diagnosis. Compared with girls with low lead levels (<5 µg/dL) and adequate maternal HDL levels (>60.7 mg/ dL), boys with high lead levels and lower maternal HDL levels had a 10-fold increased odds of having any ADHD diagnosis (OR, 10.03; 95% CI, 4.38-22.97). This increased risk was decreased by more than one-half if the mother had adequate maternal HDL levels (OR, 4.77; 95% CI, 1.76-12.90).
Similarly, boys with high lead levels and high maternal stress during pregnancy had almost a 15-fold increased odds of having any ADHD diagnosis, compared with girls with low lead levels and low maternal stress (OR, 14.94; 95% CI, 6.88-32.41). This increased risk was reduced by more than one-half if the mother had low maternal stress during pregnancy (OR, 6.10; 95% CI, 2.18-17.08). Figure 7 (available at www.jpeds.com) shows the percentage of ADHD diagnosis by maternal HDL level, maternal stress during pregnancy, and early childhood lead measurement groups among boys. The within-sex-group comparison together with the findings shown in Figure 7 also THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 199 indicate that the risk of ADHD diagnosis was lower for those born to mothers with adequate maternal HDL and low maternal stress during pregnancy given the same level of lead exposures for boys.
Table XI (available at www.jpeds.com) and Table XII (available at www.jpeds.com) show the additional sensitivity analyses to examine the independent and joint effect of gestational age and birthweight with early childhood lead exposure on ADHD. There was no indication of interaction between early childhood lead exposures and gestational age on ADHD, and the same is true for birthweight.
Discussion
This study demonstrates that moderately elevated lead levels (5-10 µg/dL) in early childhood are associated with an increased risk of ADHD in a US predominantly urban, lowincome minority birth cohort. Our findings are consistent with previous research regarding the effects of lead exposure on the risk of ADHD, although existing data were mostly crosssectional in design. 10 Our study has contributed new information to the field. We revealed a significant sex difference in the association between lead exposure and ADHD. When we stratified the MLR analysis by sex, we found no significant association between elevated lead levels (5-10 µg/dL) and ADHD among girls, but a strong association with ADHD among boys, a finding not explained by a sex difference in lead exposure. Moreover, a small prospective study (n = 195) also found similar boy-specific lead effects, which revealed that both prenatal and childhood average lead levels (<78 months of age) were associated with attention factor of neuropsychological measures only within boys. 18 Taken together, the findings from previous studies and ours suggest that boys are more vulnerable than girls to the adverse effects of early life low-level lead exposures.
In the context of early childhood lead exposure and ADHD in boys, we identified several potential protective factors that may attenuate the lead-ADHD association. We found that high maternal HDL levels and low maternal stress during pregnancy could partially counteract the increased odds of ADHD associated with early life lead exposure in boys. Except for the subgroups with sample sizes that were too small, our findings showed that high maternal HDL levels and low maternal stress during pregnancy could decrease the odds of ADHD by more than one-half compared with their counterparts. Conversely, boys born to mothers with low HDL and high stress during pregnancy were more vulnerable to the adverse effects of lead exposure on the risk of ADHD, given their level of lead exposure.
Within a subset of samples with both early childhood and maternal blood lead levels measured at delivery, we further explored whether the association we identified could be altered if we further adjusted for maternal lead levels. We found that the sex-specific relationship between the early childhood lead level and the risk of ADHD remained even after adjusting for maternal lead levels. Furthermore, we found no correlation between maternal lead levels and early childhood lead levels. This finding is consistent with the correlation results reported in a previous study, which measured the lead levels of nearly 100 mother-child pairs from Montevideo, Uruguay. NT was defined as without any neurodevelopmental disorder diagnosis; ADHD was defined as any ADHD diagnosis; the multiple logistic regression model was adjusted for maternal age at delivery, maternal race/ethnicity, maternal education, smoking during pregnancy, intrauterine infection, parity, child's sex, mode of delivery, preterm birth, and birthweight. 
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Although lead exposure in children has decreased in the US since the ban of leaded gasoline, 9 lead exposure has remained a significant risk factor for certain segments of children for 2 major reasons. First, accumulating evidence has revealed that even low-level lead exposures still have adverse effects on neurodevelopment. As a result, the identified blood lead level of concern for the fetus or young child has been revised many times from 40 µg/dL to the current CDC guidelines, which specify that there is no safe level of exposure. 6, 9, [20] [21] [22] Indeed, more recent research lends even further support for the CDC guidelines that there is no threshold for the adverse health effects of lead exposure. 8, 9 Second, although any exposure is considered unsafe, there remain profound disparities in who is more exposed to lead in the US. A study conducted in South Carolina showed that the soil lead concentration was much higher in urban areas because of more potential lead sources based there, such as road networks and industries. 23 Related to this, low-income and racial/ethnic minority individuals, including children aged younger than 6 years, have a much greater risk of lead exposure because they are the ones who tend to live in these urban areas and in neighborhoods that are closer to these lead sources. 23 Additionally, children are more biologically susceptible to the toxic effects of lead compared with adults owing to their much higher gastrointestinal bioaccessibility to lead. 24 In the BBC, about 9% of children had blood lead levels of greater than 5 µg/dL. Consistently, many other studies have also found that low-income minority populations are more likely to live in highly lead-contaminated areas and have higher median blood lead concentrations, particularly among children. 23, [25] [26] [27] Third, our data suggest that urban low-income populations may be more vulnerable to lead toxicity owing to other risk factors, including maternal dyslipidemia and high stress, as we demonstrated in this study. As such, lead remains a significant public health concern, especially for poor pregnant mothers and their children living in lead-contaminated areas.
The exact neurotoxicological pathways by which lead exposure affects ADHD risk remain unclear. Current biological studies suggest that lead disrupts the hippocampal region of the brain through interaction with the N-methyl-d-aspartate receptor both synaptically and extrasynaptically. 28 The leadinduced damage in the developing brain preferentially occurs in the prefrontal cortex, hippocampus, and cerebellum, [29] [30] [31] and not surprisingly the brains of individuals with ADHD also show a decrease in the volume and activity of the prefrontal cortex and cerebellum. 32 The neurotoxicity induced by lead depends on both age 33 and lead exposure level. 34 Compared with adults, children not only absorb more lead, but they do so directly into the brain owing to a greater potential intake from the environment and an underdeveloped blood-brain barrier. 35, 36 Moreover, the fetus is also at a high risk of lead exposure via transplacental transfer during pregnancy, which is a particularly sensitive period for fetal central nervous system development. 37, 38 The striking sex difference in ADHD is well-observed but poorly understood. An animal study showed that lead toxicity behaves differently in males and females. 39 After treating with lead acetate, female rabbits showed an earlier and higher increase in Zn protoporphyrin (a screening marker for lead poisoning 40 ) than males. 39 However, to date, no study has explained the biological mechanism behind male dominance in ADHD and sex differences in lead neurotoxicity in humans. Some have postulated that the sex difference in the lead-ADHD association might be explained by the sex difference in lead metabolism. 41, 42 Over 90% of lead is stored in bone with an average of a 10 year half-life. 41 A study on occupational lead exposure showed that the rate of bone lead release for women is slower than it is for men. 42 Moreover, a study of Swedish twins showed that the genetic factors related to lead uptake and storage explain nearly 60% of the blood lead levels among nonsmoking women. In contrast, nonsmoking men's blood lead levels mainly reflect environmental exposures. One study identified 3 polymorphic genes that influence lead accumulation and toxicokinetics. 43 These genes are responsible for encoding enzyme delta-aminolevulinic acid dehydratase, the vitamin D receptor, and the human hemochromatosis protein. 43 It is possible that the weak association between blood lead levels and risk of ADHD among girls might be due to a sex difference in the frequency and expression of these genes. 44 Our study had several limitations. First, the early childhood blood lead measurements obtained during routine pediatric screening could not precisely assess the very lowest lead exposures owing to a detection limit of 2 µg/dL. As a result, we could not examine the dose-response relationship between lead levels less than 2 µg/dL and ADHD. 2 Second, the EMR data used in our study (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) spanned the transition of the Diagnostic and Statistical Manual of Mental Disorders (DSM) from the DSM-IV-TR to the DSM-V edition. 45 However, this transition did not affect our ADHD determination 46 in children, because the main changes from DSM-IV-TR to DSM-V were more relevant to the adult diagnostic criteria. Third, missing information on lead levels and major covariates can cause selection bias if the missing information is not at random. However, we compared children with and without lead measurements and did not find a systematic difference among major covariates. Last, although we adjusted for multiple major risk factors identified in previous studies, data related to multiple family-related factors such as poor parenting, 47 ,48 maltreatment, 49 conflict/parent-child hostility, 50 and severe early deprivation 51, 52 were not available in BBC. Thus, we could not wholly eliminate potential residual confounding in this study. However, those factors are less likely to share the same biological mechanism in their effect on neurodevelopment. Thus, we do not anticipate that they had a significant impact on the association between early childhood lead and risk of ADHD, even if it was possible to adjust for those factors. ■ NT is defined as without any mental disorder diagnosis; ADHD is defined as any ADHD diagnosis; the cox proportional hazard model was adjusted for maternal age at delivery, maternal race/ ethnicity, maternal education, smoking during pregnancy, intrauterine infection, parity, child's sex, mode of delivery, preterm birth, and birthweight. No ADHD was defined as without any ADHD diagnosis; ADHD was defined as any ADHD diagnosis; the multiple logistic regression model was adjusted for maternal age at delivery, maternal race/ethnicity, maternal education, smoking during pregnancy, intrauterine infection, parity, child's sex, mode of delivery, preterm birth, and birthweight. NT was defined as without any neurodevelopmental disorder diagnosis; ADHD was defined as any ADHD diagnosis; the multiple logistic regression model was adjusted for maternal age at delivery, maternal race/ethnicity, maternal education, smoking during pregnancy, intrauterine infection, parity, child's sex, mode of delivery, preterm birth, and birthweight. NT was defined as without any neurodevelopmental disorder diagnosis; ADHD was defined as any ADHD diagnosis; the multiple logistic regression model was adjusted for maternal lead levels right after delivery, maternal lead levels, maternal age at delivery, maternal race/ethnicity, maternal education, smoking during pregnancy, intrauterine infection, parity, child's sex, mode of delivery, preterm birth, and birthweight. NA, Not applicable. NT was defined as without any neurodevelopmental disorder diagnosis; ADHD was defined as any ADHD diagnosis; the multiple logistic regression model was adjusted for maternal age at delivery, maternal race/ethnicity, maternal education, smoking during pregnancy, intrauterine infection, parity, child's sex, mode of delivery, preterm birth, and birthweight. NT is defined as without any mental disorder diagnosis; ADHD is defined as any ADHD diagnosis; the multiple logistic regression model was adjusted for maternal age at delivery, maternal race/ ethnicity, maternal education, smoking during pregnancy, intrauterine infection, parity, child's sex, and mode of delivery. NT is defined as without any mental disorder diagnosis; ADHD is defined as any ADHD diagnosis; the multiple logistic regression model was adjusted for maternal age at delivery, maternal race/ ethnicity, maternal education, smoking during pregnancy, intrauterine infection, parity, child's sex, and mode of delivery.
